NeoGenomics Inc (NEO)
NeoGenomics Reports Third Quarter 2025 Results
Aldeyra Therapeutics Inc. (ALDX)
Aldeyra Therapeutics Announces Positive Results from Phase 2 Clinical Trial in Alcohol-Associated Hepatitis, Focuses RASP Product Candidate Pipeline on Next-Generation Molecules
Invivyd Inc (IVVD)
Invivyd to Host Webcast on the REVOLUTION Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
IQVIA Holdings Inc. (IQV)
IQVIA Reports Third-Quarter 2025 Results
Ocular Therapeutix Inc (OCUL)
Ocular Therapeutix™ to Report Third Quarter 2025 Financial Results on November 4, 2025
Entrada Therapeutics Inc. (TRDA)
Entrada Therapeutics to Present at Upcoming Investor Conferences
Kymera Therapeutics Inc (KYMR)
Kymera Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025
Nutriband Inc. (NTRB)
Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch
Castle Biosciences Inc (CSTL)
Castle Biosciences to Participate in Upcoming Investor Conferences
Natera Inc (NTRA)
Natera Reports Strong Advanced Adenoma Data from Prospective PROCEED-CRC Trial, Demonstrating 22.5% Sensitivity and 91.5% Specificity